🇺🇸 FDA
Pipeline program

Dexamethasone

IEDAT-01

Phase 2 small_molecule completed

Quick answer

Dexamethasone for Nervous System Disorder is a Phase 2 program (small_molecule) at Quince Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Quince Therapeutics
Indication
Nervous System Disorder
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials